Research
Metabolic adaptation
THDBH120 is a novel long-acting dual GIPR/GLP-1R agonist that has superior weight loss and metabolic improvement effects in rodents and mammals.
THDBH120 may be a promising treatment option for obesity and metabolic disorders.
StrongSupportsmedium confidence
THDBH120 is a novel long-acting dual GIPR/GLP-1R agonist that has superior weight loss and metabolic improvement effects in rodents and mammals.
Why this rating
Based on study design from abstract.
Source
A novel GIPR/GLP-1R dual agonist improves systemic metabolism through differentially regulating inflammation and lipid metabolism in obesity
Feng Zhang et al. · Journal of Advanced Research · 2026
DOI 10.1016/j.jare.2026.02.006
other
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →